13F HOLDINGS REPORT
Defilade Capital Management, L.P.
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0002088557-26-000002
Total Value
$737.7M
Positions
33
Other Managers
0
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PFIZER INC | PFE | 2,203,504 | $54.9M | 7.44% |
| 2 | ABBVIE INC | ABBV | 227,669 | $52.0M | 7.05% |
| 3 | NOVARTIS AG | NVSEF | 362,816 | $50.0M | 6.78% |
| 4 | ICU MED INC | ICUI | 340,745 | $48.6M | 6.59% |
| 5 | PACS GROUP INC | PACS | 1,145,485 | $44.0M | 5.96% |
| 6 | ELI LILLY & CO | LLY | 31,950 | $34.3M | 4.65% |
| 7 | STERIS PLC | STE | 135,307 | $34.3M | 4.65% |
| 8 | OLEMA PHARMACEUTICALS INC | OLMA | 1,234,634 | $30.9M | 4.18% |
| 9 | REVOLUTION MEDICINES INC | RVMDW | 363,454 | $28.9M | 3.92% |
| 10 | BIOGEN INC | BIIB | 161,992 | $28.5M | 3.86% |
| 11 | NUVALENT INC | NUVL | 269,043 | $27.1M | 3.67% |
| 12 | INTUITIVE SURGICAL INC | ISRG | 45,662 | $25.9M | 3.51% |
| 13 | HENRY SCHEIN INC | HSIC | 320,422 | $24.2M | 3.28% |
| 14 | GLOBUS MED INC | GMED | 267,212 | $23.3M | 3.16% |
| 15 | XENCOR INC | XNCR | 1,414,755 | $21.7M | 2.94% |
| 16 | COGENT BIOSCIENCES INC | COGT | 568,619 | $20.2M | 2.74% |
| 17 | ALIGN TECHNOLOGY INC | ALGN | 128,060 | $20.0M | 2.71% |
| 18 | ASCENDIS PHARMA A/S | ASND | 85,694 | $18.3M | 2.48% |
| 19 | DEXCOM INC | DXCM | 244,881 | $16.3M | 2.20% |
| 20 | BECTON DICKINSON & CO | BDX | 81,207 | $15.8M | 2.14% |
| 21 | ATRICURE INC | ATRC | 397,636 | $15.7M | 2.13% |
| 22 | LIVANOVA PLC | LIVN | 241,413 | $14.9M | 2.01% |
| 23 | ALPHATEC HLDGS INC | ATEC | 626,754 | $13.2M | 1.79% |
| 24 | DENALI THERAPEUTICS INC | DNLI | 656,713 | $10.8M | 1.47% |
| 25 | GLAUKOS CORP | GKOS | 91,703 | $10.4M | 1.40% |
| 26 | RXSIGHT INC | RXST | 913,090 | $9.5M | 1.29% |
| 27 | ELANCO ANIMAL HEALTH INC | ELAN | 401,283 | $9.1M | 1.23% |
| 28 | INSMED INC | INSM | 50,000 | $8.7M | 1.18% |
| 29 | OCULAR THERAPEUTIX INC | OCUL | 681,663 | $8.3M | 1.12% |
| 30 | TELEFLEX INCORPORATED | TFX | 42,850 | $5.2M | 0.71% |
| 31 | ELEDON PHARMACEUTICALS INC | ELDN | 3,290,450 | $5.0M | 0.67% |
| 32 | CONMED CORP | CNMD | 104,129 | $4.2M | 0.57% |
| 33 | EVOMMUNE INC | EVMN | 215,418 | $3.7M | 0.50% |